Autopsy and Case Reports
https://autopsyandcasereports.org/article/doi/10.4322/acr.2021.272
Autopsy and Case Reports
Clinical Case Report

Encapsulating peritoneal sclerosis in liver transplant

Gabriel Melki; Abdalla Mohamed; Mina Fransawy Alkomos; Alisa Farokhian; Sohail M. Chaudhry; Varun Patel; Walid J. Baddoura

Downloads: 0
Views: 164

Abstract

Encapsulating peritoneal sclerosis occurs due to chronic irritation of the peritoneal surface resulting in inflammation and fibrosis. Encapsulating peritoneal sclerosis usually occurs in patients requiring peritoneal dialysis (PD); however, it may also occur in liver transplant patients. The fibrosis in encapsulating peritoneal sclerosis could be severe enough to cause small bowel obstruction (SBO). Herein, we report a case of encapsulating peritoneal sclerosis secondary to liver transplantation that presented with SBO. The patient was started on Tamoxifen for encapsulating peritoneal sclerosis and evaluated at follow-up without any other intestinal obstruction episodes. This case demonstrates that encapsulating peritoneal sclerosis can occur as a liver transplant complication and present with small bowel obstruction.

Keywords

Peritoneal Disease, Liver Transplantation, Intestinal Obstruction

References

1 Cohen O, Abrahamson J, Ben-Ari J, Frajewicky V, Eldar S. Sclerosing encapsulating peritonitis. J Clin Gastroenterol. 1996;22(1):54-7. http://dx.doi.org/10.1097/00004836-199601000-00016. PMid:8776099.

2 Kawaguchi Y, Kwanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. Perit Dial Int. 2000;20(Suppl 4):S43-55. http://dx.doi.org/10.1177/089686080002004S04. PMid:11098928.

3 Kawanishi H, Kawaguchi Y. Prevalence and therapeutic outcome of sclerosing encapsulatingperitonitis: A multicenter study in Japan. Jin To Toseki. 2000;49:225-8. In Japanese.

4 Mekeel K, Moss A, Reddy KS, Douglas D, Mulligan D. Sclerosing peritonitis and mortality after liver transplantation. Liver Transpl. 2009;15(4):435-9. http://dx.doi.org/10.1002/lt.21702. PMid:19326414.

5 Maguire D, Srinivasan P, O’Grady J, Rela M, Heaton ND. Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg. 2001;182(2):151-4. http://dx.doi.org/10.1016/S0002-9610(01)00685-7. PMid:11574087.

6 van Bommel EF, Hendriksz TF, Huiskes AW, Zeegers AG. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006;144(2):101-6. http://dx.doi.org/10.7326/0003-4819-144-2-200601170-00007. PMid:16418409.

7 Korte MR, Yo M, Betjes MG, et al. Increasing incidenceof sever encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant. 2007;22(8):2412-4. http://dx.doi.org/10.1093/ndt/gfm171. PMid:17395649.

8 Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MGHR. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant. 2011;26(2):691-7. http://dx.doi.org/10.1093/ndt/gfq362.

9 Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24(10):3209-15. http://dx.doi.org/10.1093/ndt/gfp008. PMid:19211652.
 


Submitted date:
09/28/2020

Accepted date:
02/24/2021

Publication date:
05/06/2021

60944749a9539526b019a393 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections